...
zura-img

Zura Bio Limited Class A Ordinary Shares, Common Stock

ZURA

NAQ

$2.51

-$0.27

(-9.71%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$295.78M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
7.9474
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.31M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.14
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2 L
$6.35 H
$2.51

About Zura Bio Limited Class A Ordinary Shares, Common Stock

Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops Tibulizumab, an IgG-scFv bispecific dual-antagonist antibody engineered by the fusion of ixekizumab and tabalumab that neutralizes IL-17A and BAFF, which is in Phase 2 clinical trial development; ZB-168, a monoclonal antibody that binds and neutralizes the IL-7 receptor chain that impact on diseases driven by IL7 and thymic stromal lymphopoietin immune pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in Henderson, Nevada. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameZURASectorS&P500
1-Week Return-8.39%-1.8%-0.77%
1-Month Return-46.82%-3.48%0.71%
3-Month Return-28.29%-7.2%8.81%
6-Month Return-34.46%-1.54%12.32%
1-Year Return-42.43%8.39%30.57%
3-Year Return-69.24%6.07%29.21%

Financials

Dec '21Dec '22Dec '23
Total Revenue---[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue---[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit---[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin---[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses1.09M2.68M62.64M[{"date":"2021-12-31","value":1.74,"profit":true},{"date":"2022-12-31","value":4.27,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(1.09M)(2.68M)(62.64M)[{"date":"2021-12-31","value":-109199000,"profit":false},{"date":"2022-12-31","value":-267514100,"profit":false},{"date":"2023-12-31","value":-6263800000,"profit":false}]
Total Non-Operating Income/Expense-(24.66M)4.26M[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-578.67,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income8.42M3.55M(60.56M)[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":42.17,"profit":true},{"date":"2023-12-31","value":-719.56,"profit":false}]
Income Taxes(236.56K)(570.00)(203.00K)[{"date":"2021-12-31","value":-23655800,"profit":false},{"date":"2022-12-31","value":-57000,"profit":false},{"date":"2023-12-31","value":-20300000,"profit":false}]
Income After Taxes-3.55M(60.36M)[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-1700.43,"profit":false}]
Income From Continuous Operations-(27.33M)(60.56M)[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-2733300000,"profit":false},{"date":"2023-12-31","value":-6056300000,"profit":false}]
Income From Discontinued Operations---[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income8.42M3.55M(60.36M)[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":42.17,"profit":true},{"date":"2023-12-31","value":-717.14,"profit":false}]
EPS (Diluted)0.400.25(4.44)[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":62.91,"profit":true},{"date":"2023-12-31","value":-1116.68,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

ZURA
Cash Ratio 10.32
Current Ratio 10.36

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ZURA
ROA (LTM) -21.40%
ROE (LTM) -36.85%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ZURA
Debt Ratio Lower is generally better. Negative is bad. 0.10
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.81

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ZURA
Trailing PE 7.95
Forward PE NM
P/S (TTM) 0.00
P/B 1.19
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Zura Bio Limited Class A Ordinary Shares share price today?

Zura Bio Limited Class A Ordinary Shares (ZURA) share price today is $2.51

Can Indians buy Zura Bio Limited Class A Ordinary Shares shares?

Yes, Indians can buy shares of Zura Bio Limited Class A Ordinary Shares (ZURA) on Vested. To buy Zura Bio Limited Class A Ordinary Shares from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ZURA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Zura Bio Limited Class A Ordinary Shares be purchased?

Yes, you can purchase fractional shares of Zura Bio Limited Class A Ordinary Shares (ZURA) via the Vested app. You can start investing in Zura Bio Limited Class A Ordinary Shares (ZURA) with a minimum investment of $1.

How to invest in Zura Bio Limited Class A Ordinary Shares shares from India?

You can invest in shares of Zura Bio Limited Class A Ordinary Shares (ZURA) via Vested in three simple steps:

  • Click on Sign Up or Invest in ZURA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Zura Bio Limited Class A Ordinary Shares shares
What is Zura Bio Limited Class A Ordinary Shares 52-week high and low stock price?

The 52-week high price of Zura Bio Limited Class A Ordinary Shares (ZURA) is $6.35. The 52-week low price of Zura Bio Limited Class A Ordinary Shares (ZURA) is $2.

What is Zura Bio Limited Class A Ordinary Shares price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Zura Bio Limited Class A Ordinary Shares (ZURA) is 7.9474

What is Zura Bio Limited Class A Ordinary Shares price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Zura Bio Limited Class A Ordinary Shares (ZURA) is 1.19

What is Zura Bio Limited Class A Ordinary Shares dividend yield?

The dividend yield of Zura Bio Limited Class A Ordinary Shares (ZURA) is 0.00%

What is the Market Cap of Zura Bio Limited Class A Ordinary Shares?

The market capitalization of Zura Bio Limited Class A Ordinary Shares (ZURA) is $295.78M

What is Zura Bio Limited Class A Ordinary Shares’s stock symbol?

The stock symbol (or ticker) of Zura Bio Limited Class A Ordinary Shares is ZURA

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top